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Structural biologyRedox homeostasis is signiﬁcant for the survival of pro- and eukaryotic cells and is crucial for defense against
reactive oxygen species like superoxide and hydrogen peroxide. In Escherichia coli, the reduction of peroxides oc-
curs via the redox active disulﬁde center of the alkyl hydroperoxide reductase C subunit (AhpC), whose reduced
state becomes restored by AhpF. The 57 kDa EcAhpF contains an N-terminal domain (NTD), which catalyzes the
electron transfer from NADH via an FAD of the C-terminal domain into EcAhpC. The NTD is connected to the
C-terminal domain via a linker. Here, the ﬁrst crystal structure of E. coli AhpF bound with NADH and NAD+ has
been determined at 2.5 Å and 2.4 Å resolution, respectively. The NADH-bound form of EcAhpF reveals that the
NADH-binding domain is required to alter its conformation to bring a bound NADH to the re-face of the isoallox-
azine ring of theﬂavin, and thereby render theNADH-domain dithiol center accessible to theNTDdisulﬁde center
for electron transfer. The NAD+-bound form of EcAhpF shows conformational differences for the nicotinamide
end moieties and its interacting residue M467, which is proposed to represent an intermediate product-release
conformation. In addition, the structural alterations in EcAhpF due to NADH- and NAD+-binding in solution are
shownby small angle X-ray scattering studies. The EcAhpF is revealed to adoptmany intermediate conformations
in solution to facilitate the electron transfer from the substrate NADH to the C-terminal domain, and subsequently
to the NTD of EcAhpF for the ﬁnal step of AhpC reduction.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Reactive oxygen species (ROS) are inevitable byproducts during the
course of normal aerobicmetabolism. Biological cells have developed an-
tioxidant systems to regulate the endogenous level of ROS, which dam-
age the cells at higher concentration and can function as a cellular
signaling molecule at lower concentration [1,2]. Peroxiredoxins (prx), a
class of thiol-speciﬁc antioxidant proteins, together with peroxiredoxin
reductases (prxR) are the predominant cellular defenses against oxida-
tive stress and are also involved in cellular signaling pathways [3,4].
The coordinated interplay between prx and prxR is essential for
enhanced peroxidative catalytic rates. Many bacteria possess an alkyl
hydroperoxide reductase (AhpR) system, composed of the two most
abundant enzymes called AhpF (prxR) and AhpC (prx), which together
catalyze the NADH-dependent reduction of H2O2 [5–7]. AhpC undergoes
oligomeric states,which are redox-sensitive. ReducedAhpCpreferentiallyassembles ﬁve catalytic dimers into a doughnut-like decamer, whereby
the oxidized form of the protein leads to a lower order of oligomers
between decamer and dimer [8,9].
AhpF is a homo-dimeric protein and belongs to FAD-dependent
NADH protein-disulﬁde reductases. The protein consists of an
N-terminal domain (NTD), which catalyzes the reduction of redox-
active disulﬁdes in AhpC [10,11] (Fig. 1). The NTD is connected via a
linker to the C-terminal catalytic core, containing an FAD- and NADH
binding domain with the redox-active disulﬁde (C345/C348 according
to Escherichia coli numbering). With regard to catalytic mechanism,
AhpF has been proposed to alternate between two states known as
ﬂavin-oxidized (FO) and ﬂavin-reduced (FR), in-order to accomplish
the series of intra-molecular electron transfers from NADH to FAD and
to the redox active disulﬁde, as well as the release of the oxidized
NAD+ [12–14]. The cascade of electron transfers from NADH via FAD,
to the C-terminal redox-active center (C345/C348) followed by the di-
sulﬁde center (C129/C132) of the NTD would provide the electrons for
the redox-active center (C47/C166) of AhpC [11,15]. Apparently, con-
formational rearrangements of the NTD and C-terminal domain (CTD)
Fig. 1. Structural details of AhpF: cartoon representation of the structures available for full-lengthAhpF show the extended (I) and compact (III) conformations. (II) Themodel represents the lack
of structural details for substrate binding and the alternating conformation of the NADH-domain. (IV) The plausible model, showing the ﬂexibility of the N-terminal domain during elec-
tron transfer. The arrows in panels II and IV indicate the ﬂexibility of the N-terminal domain of AhpF. For clarity, the AhpF molecule is shown as a monomer.
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cent crystallographic structures of the E. coli [11] (PDB ID: 4O5Q) and
Salmonella typhimurium [16] (StAhpF, PDB ID: 1HYU) AhpF revealed
an elongated and a compact conformation, respectively (Fig. 1). The
elongated form of EcAhpF is proposed to have a prominent role in
AhpC reduction, in which the dimeric EcAhpF binds to the AhpC
decamer [11]. In comparison, the compact conformation shown in the
StAhpF structure potentially mimics the disulﬁde–dithiole exchange
taking place between the NTD and CTD redox centers, even though
they are not in a proximity for electron transfer to occur [16] (Fig. 1III).
So far, the structural studies on the apo-form of AhpF reveal only the
FO-state of the NADH-domain (Fig. 1I and III), where the NADH-redox
active disulﬁde is adjacent to the ﬂavin. However, no detailed structural
insight is available with regard to substrate binding, speciﬁcity and the
intra-molecular electron transfer mechanism (Fig. 1II) [11,16,17]. In ad-
dition, the degree of conformational ﬂexibility and possible relevant in-
termediate conformations of theNTD in solution is not yet characterized
(Fig. 1IV). Here, an attempt has beenmade to solve the crystal structureof E. coli AhpFwith NADH or NAD+ bound to the enzyme. The ﬁrst crys-
tal structure of EcAhpF with bound substrate implies that the NADH-
domain is required to rotate relative to the FAD-domain by 65°. The un-
derlying intra-molecular electron transfer mechanism is discussed. The
existence and the extent of conformational ﬂexibility of the NTD are
demonstrated using SAXS, studying the NADH- and NAD+-bound
forms of EcAhpF in solution.
2. Materials and methods
2.1. Crystallization of the NADH- and NAD+-bound forms of EcAhpF
The puriﬁcation of EcAhpFwas carried out using a recently published
method [11]. The puriﬁed protein was concentrated to 10 mg/ml in a
buffer composed of 50 mM Tris/HCl (pH 8) and 200 mM NaCl. Plate-
shaped crystals with the dimensions of 0.25 × 0.12 × 0.05 mmwere ob-
tained by the micro-seeding method with the precipitant solution of
0.1 M Na-HEPES (pH 7.5), 2.5% (v/v) PEG 400, 2 M ammonium sulfate
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hanging-drop vapor-diffusionmethod, were transferred into the crystal-
lization buffer solution, which contained different concentrations of
NADH or NAD+ ranging from 10 to 50 mM. Crystals were soaked over
different time periods (1 h to 24 h) and transferred into a cryo-
protectant including 20% glycerol in their reservoir solutions and ﬂash-
cooled in liquid nitrogen for data collection.
2.2. Data collection and structure determination of substrate bound forms
of EcAhpF
Single wavelength datasets for the NADH- and NAD+-soaked E. coli
AhpF crystals were collected at 140 K at beamline 13B1 of the National
Synchrotron Radiation Research Center (NSRRC, Hsinchu, Taiwan)
using the ADSC Quantum 315 CCD detector. The NADH- and NAD+-
soaked crystals diffracted to 2.5 Å and 2.4 Å resolution, respectively.
The data-sets of both crystal forms were indexed, integrated and scaled
using Mosﬂm [18] and HKL2000 [19], respectively. The data collection
and processing statistics are summarized in Table 1. Both structuresTable 1
Data collection, processing and reﬁnement statistics of the substrate bound EcAhpF.
NADH NAD+
Wavelength (Å) 1.000 1.000
Crystal-to-detector distance
(mm)
320 300
Rotation range per image (°) 1 1
Total rotation range (°) 180 200
Exposure time per image (s) 10 15
Space group C2 C2
Unit cell parameters (Å, °)
a= 107.09 106.88
b= 59.39 59.47
c= 121.35 121.51
α= 90 90
β= 111.34 111.40
γ= 90 90
Molecules in asymmetric unit 1 1
Solvent content (%) 61.01 61.7
Resolution limits (Å) 30.0–2.50
(2.60–2.50)a
30.0–2.40
(2.49–2.40)
No. of reﬂections 76,253 96,197
Unique reﬂections 22,917 26,052
Multiplicity 3.3 (3.4) 3.7 (3.4)
Completeness (%) 92.3 (85.1) 91.9 (90.7)
Rmerge
b (%) 7.4 (28.6) 8.1 (53.5)
b I//σ(I)N 10.3 (3.5) 11.9 (1.4)
CC1/2 98.8 (92.7) 93.3 (76.8)
Reﬁnement statistics
R-factorc (%) 22.79 22.39
R-freed (%) 28.82 28.53
Number of waters 150 161
Number of sulfates 10 9
Number of FAD 1 1
Number of Cadmiums 1 1
Number of PEGs 3 2
Number of glycerols 3 6
Number of NADH/NAD+ 1 1
MolProbity statistics
Ramachandran favored (%) 94 93.4
Ramachandran outliers (%) 0 0
Clashscore 2.20 2.30
R.M.S. deviations
Bond lengths (Å) 0.015 0.012
Bond angles (°) 1.676 1.518
Overall B values
From Wilson plot (Å2) 50.42 52.00
Mean B value (Å2) 40.56 49.03
a Values in parentheses refer to the corresponding values of the highest resolution shell.
b Rmerge = ΣΣi|Ih− Ihi| / ΣΣi Ih, where Ih is the mean intensity for reﬂection h.
c R-factor=Σ||FO|− |FC|| /Σ|FO|, where FO and FC aremeasured and calculated structure
factors, respectively.
d R-free = Σ||FO|− |FC| / Σ|FO|, calculated from 5% of the reﬂections selected randomly
and omitted during reﬁnement.were solved by the molecular replacement method using the apo
EcAhpF structure [11] (PDB ID: 4O5Q). Since the N-terminal domain
did not ﬁt properly in the electron density map, the N- and C-terminal
domain structures of the apo-EcAhpF were used separately, yielding
the best solution with a continuous electron density for the entire mol-
ecule. The startingmodelwas improvedmanually using Coot [20] in be-
tween iterative cycles of restrained reﬁnement by REFMAC5 [21] of the
CCP4 suite [22]. The bound NADH and NAD+ were clearly interpreted
from the electron density map and included in the model. Reﬁnement
was done until convergence and the geometry of the ﬁnal model was
validated with MolProbity [23]. The ﬁgures were drawn using the pro-
gram PyMOL [24] and structural comparison analysis was carried out
by the SUPERPOSE program [25] as included in the CCP4 suite. Coordi-
nates and structure factors of the NAD+- and NADH-bound form of
EcAhpF have been deposited under PDB IDs: 4YKG and 4YKF,
respectively.
2.3. Production and puriﬁcation of the [3-13C]Cys-labeled CTD212–521 of
EcAhpF
The production of the EcAhpF C-terminal domain CTD212–521 con-
struct was described recently [11]. E. coli BL21 (DE3) transformed cells
were plated on LB-agar, from which a single colony was selected to
prepare a 15 ml LB seeder culture. After overnight growth, the culture
was centrifuged at 3000 ×g for 5 min at 4 °C to pellet out the cells.
The cells were washed and subsequently suspended in 1 l M9-
minimal media supplemented with MgSO4, CaCl2, thiamine, FeCl3,
trace elements and 19 unlabelled amino acids [26] with the exception
of L-cysteine. Starting with an OD600 of 0.08, the cells were allowed to
grow to an OD600 of 0.6 at 37 °C at which point the culture was induced
with isopropyl β-D-thiogalactoside to a ﬁnal concentration of 1 mM. In
addition, 25 mg of L-[3-13C] cysteine were added and the culture was
allowed to grow overnight at 20 °C. The cells were harvested by centri-
fugation at 8500 ×g for 15 min. The CTD212–521 protein was puriﬁed as
previously described [11].
2.4. 1H-13C HSQC-NMR spectroscopy of CTD212–521
Puriﬁed 13C-labeled E. coli CTD212–521 was prepared for NMR
spectroscopy experiments by buffer exchanging into phosphate buffer
(50 mM phosphate, 100 mM NaCl, and pH 6.8). 10% D2O was added to
and mixed with 180 μl of the sample. Indirect referencing using
4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) was used to calibrate
the 13C chemical shifts. The samplewas centrifuged and transferred into
a Shegami tube. All measurements were acquired on a 700-MHz NMR
spectrometer with 4 RF channels (Bruker Avance, Bremen, Germany)
equipped with a 5 mm z-gradient TXI (Triple Resonance Probes) cryo-
probe, one 4 mm HR-MAS probe, and one 5 mm z-gradient PATXI
probe. 1H-13C HSQC was acquired with 96 scans using the pulse-
program hsqcetf3gpsi2 [27–29]. In the case of CTD212–521 reduction,
10 M excess of tris(2-carboxyethyl)phosphine (TCEP) was incubated
with CTD212–521 for 20 min after which the data were acquired.
CTD212–521 was incubatedwith either NADH or NAD+ for 10min before
measurement. All data were processed using Bruker's Topspin 2.1
(Bruker, Germany) and analyzed with SPARKY [30].
2.5. Small angle X-ray scattering studies of the apo-, NADH- and NAD+-
bound EcAhpF
Small angle X-ray scattering (SAXS) data of EcAhpF were collected
with the BRUKER NANOSTAR SAXS instrument, equipped with a
Metal-jet X-ray source and VANTEC 2000-detector system. The X-ray
radiation was generated from a liquid gallium alloy with a microfocus
X-ray source (Kα= 1.3414 Å with a potential of 70 kV and a current
of 2.857 mA). The X-rays were ﬁltered throughMontel mirrors and col-
limated by a two pinhole system. The sample to detector distance was
1142 N. Kamariah et al. / Biochimica et Biophysica Acta 1847 (2015) 1139–1152set at 67 cm and the sample chamber and X-ray paths were evacuated
[11,31]. This setup covers the momentum transfer range of
0.016 b s b 0.4 Å−1 (s = 4π sin(θ) / λ, where 2θ is the scattering
angle). SAXS experiments were carried out at 15 °C with protein con-
centrations of 1, 2 and 4 mg/ml in a buffer containing 50 mM Tris/HCl,
pH 7.5, 150 mM NaCl, and a sample volume of 40 μl in a vacuum tight
quartz capillary. Similarly, the SAXS-data for NADH- and NAD+-bound
forms of EcAhpF were measured for the protein samples incubated
with 1 mM NADH or NAD+ for 30 min, respectively. Corresponding to
each protein sample, datawere collected for a buffer under identical ex-
perimental conditions, providing a background scattering curve. The
data were collected for 30 min and for each measurement a total of
six frames at 5 min intervals were recorded. The data were ﬂood-ﬁeld,
spatial corrected and processed using the built-in SAXS software. The
data were tested for possible radiation damage by comparing the six
data frames, which indicated no change. The scattering of the corre-
sponding buffer was subtracted and the difference curves normalized
for the concentration as well as initial intensity. All the data processing
steps were performed using the program package PRIMUS [32]. The ex-
perimental data obtained for all forms of EcAhpF were analyzed for ag-
gregation using the Guinier region [33]. The forward scattering I(0) and
the radius of gyration, Rgwere computed using the Guinier approxima-
tion assuming that at very small angles (s b 1.3 / Rg) the intensity is rep-
resented as I(s) = I(0) · exp(−(sRg)2 / 3) [33]. These parameters were
also computed from the extended scattering patterns using the indirect
transformpackageGNOM [34],whichprovides the distancedistribution
function p(r) hence the maximal particle dimension, Dmax, and Rg. The
normalized Kratky plot [35] was generated by normalizing the scatter-
ing intensity I(s) to the forward scattering I(0), and the scattering vector
s to the radius of gyration Rg. The normalized Kratky-plot is used to as-
sess the conformational behavior of the polypeptide chain. The Porod–
Debey plot [36] was generated by transformation of the scattering
data as s4 I(s) vs. s4. The Porod–Debey region describes the nature of
the scattering intensity decay, which gives information about the ﬂexi-
bility of the particle. Low resolution models of the protein were built by
the programDAMMIN [37] considering low angle data (s b 0.2 Å−1). Ab
initio solution shapes were obtained by superposition of ten indepen-
dent model reconstructions with the program package SUBCOMP [38]
and building an averaged model from the most probable one using the
DAMAVER program [39]. Comparison of the experimental scattering
curve with the theoretical scattering curves calculated from available
high resolution crystal structures were performed with CRYSOL [40].
The models were then used in OLIGOMER [32] to ﬁnd the best ﬁt to a
multi-component mixture of proteins. Rigid body modeling was per-
formed with the dimer model of EcAhpF (PDB ID: 4O5Q) using the soft-
ware CORAL [41], that allows the ﬂexibility of the loop region (residues
197–214), which connects theNTDand CTD. Quantitative assessment of
ﬂexibility was done using the Ensemble Optimization Method (EOM
2.0) [42], which assumes coexistence of a range of conformations in so-
lution for which an average scattering intensity ﬁts the experimental
data. In EOM 2.0, a random pool of 10,000 independentmodels is creat-
ed as a ﬁrst step with the aim to approximate the conformational space
for a protein exhibiting considerablemotion. For eachmodel in the pool,
a theoretical scattering curve is automatically computed by using
CRYSOL [40]. Afterwards, a genetic algorithm (GA) is used to select en-
sembleswith varying numbers of conformers by calculating the average
theoretical proﬁle and ﬁtting it to the experimental SAXS data.
3. Results
3.1. The overall structure of NADH- and NAD+-bound EcAhpF
Crystals soaked overnight in a solution with 10 mM NADH and
NAD+ diffracted to 2.5 Å and 2.4 Å resolution, respectively, and
belonged to the space group C2 with essentially identical unit cell pa-
rameters (Table 1). Based on the solvent content of 61% and aMatthewsco-efﬁcient (Vm) of 3.15 Å3 per Dalton [43], onemolecule per asymmet-
ric unit was assumed. The crystal structure of E. coli AhpF bound with
NADH or NAD+ contains one molecule in the asymmetric unit with al-
most all residues ﬁtting well into the electron density, except for the
residues D196–E200 (Fig. 2). A clear electron density was observed for
NADH and NAD+ which are bound in the deﬁned NADH-binding do-
main (Fig. 3A). In addition, an FAD-molecule, cadmium ion, PEG, glycer-
ol and sulfate molecules were also identiﬁed in the structures (Table 1).
The EcAhpF structure comprises three major domains; an N-terminal
domain (aa 1–196), the FAD- (aa 210–327 and 450–521) and the
NADH-binding (aa 328–449) domains (Fig. 2A). The NADH- and
NAD+-bound structures are similar with an R.M.S. deviation of 0.49 Å
for the backbone Cα atoms of the 521 residues in the monomer
(Fig. 2A). Comparison of individual domains yielded the R.M.S. differ-
ences of 0.37, 0.29 and 0.17 Å for the backbone Cα atoms of the
N-terminal-, FAD- and NADH-domains, respectively. The average
B-factor for the main chain atoms of the N-terminal-, FAD- and NADH-
binding domains were 58.6 and 72, 22.7 and 29.5 and 26.6 and
31.5 Å2 for NADH- and NAD+-bound structures, respectively.
TheNTD, which resembles two thioredoxin like folds fused together,
has one 129CXXC132 motif at their C-terminal thioredoxin fold (Fig. 2A).
In the presented NADH- and NAD+-bound structures, the NTD redox
center (C129–C132) is in the oxidized form. In the FAD-domain
(210–327 and 450–521), a FAD-cofactor is bound and accommodated
well in its binding pocket (Fig. 2A). TheNADH-domain has similar struc-
tural features to the FAD-domain and contains a redox active center
(C345–C348), which is in close vicinity to the FAD-cofactor and is in ox-
idized form with the S–S distance of 2.06 Å in the NADH-bound struc-
ture (Fig. 2B). In addition, the C345 sulfur atom has hydrogen-bond
interaction with the water molecule. Surprisingly, the electron density
of the C-terminal redox center (C345–C348) in the NAD+-bound struc-
ture suggests that it is reduced, with a large extra blob of density on the
C345 residue (Fig. 2C). Modeling alternative conformations for this cys-
teine residue does not yield a map that is devoid of mFo-DFc difference
features, suggesting that it might have beenmodiﬁed (Fig. 2D). Various
oxidization states of cysteines, like sulfenic, sulﬁnic and sulfonic, were
modeled. Themapwas satisﬁedwith the sulﬁnic acid (C345-SOOH) ox-
idized form that adopts two alternate conformations (Fig. 2E). Here, one
of the side chain conformations of the sulﬁnic acid is stabilized by the
hydrogen bond interactions with the back bone nitrogen of H347 and
side chain nitrogen atom of Q496 and a water molecule, while the
other side chain conformation has a hydrogen bond with the side
chain nitrogen atom of W326.
To test the possibility that the C345 modiﬁcation is non-native or
whether this site may be especially reactive towards oxidants, NMR
studies using 13C-labeled cysteines of CTD212–521 were carried out. In
these experiments, we made use of the knowledge that, if a chemical
shift in the 13C-dimension of a cysteine is b32 ppmor N35 ppm, the cys-
teine residue exists in a reduced or oxidized state, respectively. The
1H-13C-HSQC of 13C-labeled CTD212–521 reveals a 13C-chemical shift
peak at 39.6 ppm, indicating a disulﬁde formation between C345 and
C348 in the NADH-binding domain (Supplemental Fig. S1A). To conﬁrm
the observed disulﬁde bond at 13C = 39.6 ppm, 10 M excess of TCEP
was added to the protein, leading to the disappearance of the suspected
–SS– peaks and the appearance of reduced peaks at 13C = 30.49, 28.71
and 23.34 ppm (Supplemental Fig. S1B). In comparison, NADH incuba-
tion of 13C-Cys CTD212–521 did not yield any reduced forms (Supplemen-
tal Fig. S1C). However, there was an appearance of a strong peak at
57.55 ppm (CysSO2 or/and CysSO3). AhpF is known to function as an
NADH-oxidase, which catalyzes the FAD-dependent oxidation of
NADH by simultaneous reduction of oxygen to H2O2 [44,45]. The H2O2
formed during the NADH-oxidation is likely to react with the cysteine
to form sulﬁnic or sulfonic acid peaks as observed at 57.55 ppm. Finally,
the addition of NAD+ did not yield any difference in the spectrum com-
pared to the apo-form of CTD212–521 (Supplemental Fig. S1D), indicating
that the C345 modiﬁcation in the presence of NAD+ observed in the
Fig. 2. Crystal structures of the NADH- andNAD+-bound EcAhpF. (A) Cartoon representation of the superimposition of theNADH- (wheat) andNAD+- (brown) bound forms of EcAhpF struc-
tures. TheNADH- and NAD+-substrates are shown as sticks inmagenta and violet, respectively. In 90° view, the ﬂavin cofactor in the FAD-domain is depicted in yellow sticks in the center
of the EcAhpF structure. (B) ThemFo-DFcOMITmap (green) contour at 3σ level around the redox center where residues are omitted for calculation. The NADH-domain redox center is in
disulﬁdebond conformation as interpreted from themapof theNADH-bound structure. (C) ThemFo-DFcOMITmap (green) contour at 3σ level for theNAD+-bound structure. A large blob
of density is observed for residue Cys345. (D) The superposition of the 2mFo-DFc (blue) at 1σ andmFo-DFc (green) at 3σ electron density maps shows a residual positive density (green)
near the Cysteine 345 position indicating a possible modiﬁcation. (E) 2mFo-DFc (blue) map at 1σ with the modeled C345-SOOH in two different conformations.
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X-ray data collection [46–48].
As shown in Fig. 3B, the NADH-domain is connected to the FAD-
domain through two small polypeptide stretches, L325–N327 andQ448–L451. The contacts between both domains are mainly formed
by the interaction between the isoalloxazine-ring of FAD with the
345CXXC348 redox-center. The C348 has the shortest distance of 3.1 Å
with the FAD molecule and the sulfur atom of C348 making interaction
Fig. 3. NADH- and NAD+-binding in the nicotinamide-binding domain. (A) The 2mFo-DFc composite OMIT-maps contoured at 1σ level for NADH (magenta) and NAD+ (violet) show clear
density for the substrates. (B) Cartoon representation of the NADH-binding domainwith bound NADH and NAD+, respectively, at the conserved βαβαβ-motif. The hydrogen bond inter-
action pattern for the residues involved in direct (C) as well as water mediated hydrogen bond interaction (D) with the substrate NADH. (E) Superposition of the NADH- and NAD+-sub-
strate binding region. Signiﬁcant conformational differences are observed for the nicotinamide end moieties. The side chain conformation of M467 is signiﬁcantly different between the
two forms and involves hydrogen bond interaction with nicotinamide-ribose in NADH-form.
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NADH-domains are responsible for the dimer formation in the EcAhpF
structure by forming a head-to-tail homodimer (Supplemental
Fig. S2). The linker region (197GAEKRAAEELNK209) between the NTD
and FAD-domain adopts a loop–helix conformation with the loop
(197–202) being highly disordered, and the helical region (203–208)
showing clear density for main-chain- as well as side-chain atoms.
3.2. A close look at the substrate binding pocket
The NADH- and NAD+ positions are clearly deﬁned in the electron
density map (Fig. 3A) except for the nicotinamide moiety carboxylic
amide group of NAD+. The substrates are bound to the NADH-binding
domain in a well-deﬁned manner by positioning the nicotinamide
ring oriented towards the FAD-bindingdomain and the adenine-ring to-
wards the anti-parallel strands of the NADH-binding domain (Fig. 3B).
The NADH-binding domain of the EcAhpF structure contains a typical
nucleotide binding site with the conserved β–α–β–α–β motif or
Rossman fold (residues 357–409). In addition, the residues of
the β(7)-strand (aa 444–447) and the anti-parallel β(4–6)-sheet
(aa 412–441) interact with the substrates. The NAD(H)-binding site
contains the conserved glycine-rich loop 362GXGXXG367, which con-
nects the ﬁrst β(1)-strand and the α(2)-helix of the β–α–β–α–β
motif (Fig. 3B).
NADH is involved in direct as well as water-mediated hydrogen
bond interaction with the protein as shown in Fig. 3C–D. The adenine-
moiety of the NADH-molecule is mainly surrounded by hydrophobic
residues (F386, I361 and I449), and forms hydrogen-bond interactions
with the backbone and side chain atoms of F386. The side chains of
I361 and I449 are also involved in the hydrogen-bond interactions
with this moiety. Additionally, water-mediated hydrogen bond interac-
tions are also observed between the adenine-moiety and both T414 and
the backbone carbonyl-oxygen atom of A412 located at the anti-parallel
β-sheet. The adenine-ribose hydroxyls form strong hydrogen bond in-
teraction with the carboxylate of the negatively charged E385, and in-
teract with the backbone nitrogen atom of G364. One of the
pyrophosphate molecules, which is close to adenine ribose, forms
hydrogen-bond interaction with G364, while the second phosphate
molecule that is close to the nicotinamide ribose forms hydrogen-
bond interactions with the backbone nitrogen atoms of N365 and
S366. These residues create the positive charge environment around
the negatively charged pyrophosphate. The pyrophosphate molecule
is also involved in direct as well as water-mediated hydrogen-bond in-
teractions with the side chain hydroxyl of S366. In addition to the three
glycine residues (G364, Gly367, and G450), Q448 andW328 are also in-
volved in the water-mediated hydrogen-bond interactions with pyro-
phosphate. The nicotinamide-ribose has hydrogen-bond interaction
with the sulfur-atom of M467, which is the only residue of the FAD-
binding domain that interacts with the substrate NADH.
In comparison, theNAD+-molecule binds at a position similar to that
of the NADHmolecule (Fig. 3E). Although both substrates adopt an ex-
tended conformation where the distance between the C6A-atom of
nicotinamide- and C2N-atom of the adenine-ring is about 18 Å, a signif-
icant conformational difference is observed for the nicotinamide- and
ribose-moieties. The conformational difference is characterized by the
χN (O4D–C1D–N1N–C2N), γN (O5D–C5D–C4D–C3D) and βN (PN–
O5D–C5D–C4D) angles, which vary from −123.43° to −162.31°,
12.27° to 16.84° and−149.32° to 150.64° between NADH- and NAD+,
respectively. The distance between the pyrophosphate PN-atom to the
nicotinamide N1N-atom is 4.83 Å and 5.29 Å for NADH- and NAD+, re-
spectively. Although the protein residues that are involved in direct as
well as water-mediated hydrogen bond interactions with NAD+ are
identical to those of NADH, the hydrogen-bond interaction of the FAD-
domain residue M467 with the nicotinamide-ribose is absent in the
NAD+-bound form due to the signiﬁcant side-chain conformation dif-
ference (Fig. 3E). The average B-factors at the adenine-end of NADHand NAD+ are 34.1 and 29.4 Å2, respectively, and are comparable to
the B-factors of the surrounding residues (28.6 and 33.4 Å2), while the
nicotinamide moiety that does not make hydrogen bond interactions,
has relatively higher B-factors (83.3 and 65.6 Å2).
3.3. Structural comparison of the apo- and substrate-bound EcAhpF
The presented structures of the NADH- and NAD+-bound forms of
EcAhpF enable a comparison with the recently solved EcAhpF apo-
form [11]. The superimposition of the structures in Fig. 4A shows that
the folds of all four domains remain similar, resulting in an R.M.S. devi-
ation of 1.49 and 1.45 Å for 521 Cα atoms (Fig. 4A), respectively. When
the structures were overlaid based on the FAD-domain, the NTDs of
NADH- and NAD+-bound forms were seen to adopt a different confor-
mation compared to the apo-form of EcAhpF with an R.M.S. deviation
of 0.44 and 0.53 Å for 196 Cα atoms, respectively. The NTDs of the
NADH- and NAD+-bound forms of EcAhpF structures have a rotation
of 8° about the axis along the molecule (Fig. 4A). Signiﬁcant structural
differences were also observed between the linker region of the apo-
and NADH/NAD+-bound forms of EcAhpF, which enable the protein to
accommodate the 8° rotation of the NTD. Comparison of the
C-terminal domain reveals R.M.S. deviations of 0.32 and 0.35, and 0.25
and 0.26 Å for the FAD- and NADH-binding domains between the apo
and NADH/NAD+-bound structures, respectively.
Although larger conformational alterations were observed for the
NTD and linker region between the substrate-bound and apo forms of
EcAhpF, subtle but signiﬁcant structural differences were also noted
for the NADH-interacting residues of the NADH-binding domain. The
conformation that is adopted by these residues may favor interaction
with the bound NADH- and NAD+-molecules (Fig. 4B). In particular,
the side chain of K391, which is oriented towards the pyrophosphate
for maintaining the positive charge environment, adopts a bent confor-
mation and is oriented away in the apo-structure. The residues I361,
S366 and I449 are shifted towards the substrate molecules. In addition,
the side chain of M467 in the NADH-bound EcAhpF adopts a favorable
conformation to interact with the nicotinamide-ribose due to a signiﬁ-
cant change in the χ2 angle compared to that of the apo-EcAhpF. Such
interaction of M467 with the nicotinamide-ribose is absent in the
NAD+-bound form, which adopts a similar conformation to that of
apo-EcAhpF. Interestingly, a signiﬁcant structural difference could also
be seen for residue W326 of the hinge region, which connects the
FAD- and NADH-binding domain [11]. The W326 side chain forms sev-
eral weak contacts with FAD and with the residues Q248 and D488 of
the FAD-binding domain in the apo-EcAhpF structure. In the
substrate-bound structures, the side chain conformation ofW326 is sig-
niﬁcantly changed in a way that ruptures interactions with the FAD-
binding domain and is involved in the water-mediated interaction
with the pyrophosphate molecule. The conformational changes ob-
served forW326 seem tohave a structural role in the alternating confor-
mation adopted by the NADH-binding domain.
3.4. Conformational changes of EcAhpF and its substrate-bound forms in
solution
In order to understand the conformational alterations of EcAhpF in so-
lution, SAXS-experiments were performed. SAXS-patterns of the EcAhpF
apo-formaswell as in the presence of 1mMNADHorNAD+were record-
ed at different protein concentrations (1, 2 and 4mg/ml) to yield the ﬁnal
composite scattering curve shown in Fig. 5A. An NADH dependent oxi-
dase assay at 1 mM of NADH revealed a sufﬁcient amount of substrate
during the SAXS experiment performed (data not shown). The solution
X-ray scattering data did not show a signiﬁcant concentration effect
(Supplemental Fig. S3) and the Guinier plots at low angles are linear
and revealed good data quality with no indication of protein aggregation
(Fig. 5A, inset). The radius of gyration (Rg) values from the Guinier ap-
proximation were consistent for all the concentrations measured with a
Fig. 4. Comparison of apo-, NADHandNAD+-bound forms of EcAhpF. (A) Superimposition of apo- (cyan), NADH-(wheat) andNAD+- (brown) forms of EcAhpF in cartoon representation. The
most signiﬁcant structural difference observed is the positioning of the NTD which is rotated by about 8° between the structures. (B) The substrate-interacting residues are shown for the
apo, NADH- and NAD+-forms. The residues are positioned in such a way as to favor the interaction with NADH- as well as NAD+.
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andNAD+-bound forms of EcAhpF, respectively. The distance distribution
functions (p(r)) were similarly shaped for all the concentrations used
(Fig. 5B) and the maximum particle dimensions (Dmax) were estimated
to be 129.5 ± 3 Å, 120.4 ± 1 Å and 120.3 ± 2 Å for the apo-, NADH-
and NAD+-bound forms of EcAhpF respectively. The data indicate that
the overall diameter and length of EcAhpF drops in the presence of
NADH or NAD+. The normalized Kratky-plot (s4I(s) vs. s4) of the apo-,
NADH- and NAD+-bound forms of EcAhpF were plotted along with the
CTD215–521 of EcAhpF (Fig. 5C). The bell-shaped proﬁle exhibited for
CTD215–521 demonstrates the globular nature of this domain, which van-
ishes for the entire EcAhpF, indicating the increase in ﬂexibility. The ab-
sence of a plateau in the Porod–Debye plot with the exponent (P) of 2.9
for both the substrate-bound and apo-form of EcAhpF, respectively, also
demonstrates the ﬂexibility of this protein (Fig. 5D). Investigation of
Kratky- and Porod–Debey plots also suggests that the addition of NADH
and NAD+ does not alter the overall ﬂexibility.
The theoretical scattering curves of amonomeric and a dimeric form
of the extended EcAhpF (PDB ID: 4O5Q) and compact StAhpF (PDB ID:
1HYU), respectively, were computed and compared with the experi-
mental solution X-ray scattering data of different forms of EcAhpF
using the program CRYSOL [40]. The dimeric form of the extended
EcAhpF (χapo2 = 1.64; χNADH2 = 1.43; χ2NADHþ = 1.84) and bent StAhpF
(χapo2 =1.78;χNADH2 =1.30;χ2NADHþ =1.52) conformations had a better
ﬁt than the monomeric extended EcAhpF (χapo2 = 6.38; χNADH2 = 4.73;
χ2NADþ = 4.29) or bent StAhpF (χapo
2 = 7.73; χNADH2 = 5.59; χ2NADHþ
= 5.38) conformations. The monomeric and dimeric extended- and
bent models, respectively, were then used in OLIGOMER [32], to ﬁnd
the best ﬁt to a multi-component mixture of AhpF in solution. A ﬁt of
the χ2-values of 0.63, 0.51 and 0.73 (Fig. 6A) was achieved for the
apo-, NADH- and NAD+-bound forms of EcAhpF, respectively, when
only both conformations of the dimer were present in equal amounts.A ratio of extended- to closed-dimeric conformation was calculated to
be 51%:49%, 48%:52% and 47%:53% for the apo-, NADH- and NAD+-
forms, respectively.3.5. SAXS-based ﬂexibility analysis for EcAhpF in solution
The SAXS-data described above formed a platform to investigate the
ﬂexibility of the NTD with the linker region relative to the CTD of
EcAhpF using three approaches. Since no aggregation or repulsion is ev-
ident in the samples, the data from the highest concentration of EcAhpF
(4.0 mg/ml) were used for all subsequent analyses. Firstly, the
gross shape of EcAhpFwas ab initio reconstructed. The average structure
of ten independent reconstructions is shown in Supplemental Fig. S4B–D,
the normalized spatial discrepancy (NSD) values being 0.78 ± 0.02,
0.73 ± 0.04, and 0.76 ± 0.03 for the apo-, NADH- and NAD+-forms, re-
spectively. The normalized Kratky-plot analysis ensures that ﬂexibility
ariseswhen the NTD tethers to the CTD through the ﬂexible linker region.
In a further analysis, we performed rigid-body modeling of the di-
meric EcAhpF (PDB ID: 4O5Q) using the SAXS data obtained for the
substrate-bound and apo-form of EcAhpF using the program CORAL
[41], allowing ﬂexibility for the loop region (aa197–214) between
NTD1–196 and CTD215–521. This program performs modeling of com-
plexes against the experimental SAXS data using a combined rigid
body for the atomic structures of the domains and the ab initiomodeling
of the unknown loop regions. As shown in Fig. 6B, the CORAL-model ﬁts
with χ2-values of 0.55, 0.44 and 0.76 for the apo-, NADH- and NAD+-
forms, respectively. The data reveal that the compact and extended con-
formation of EcAhpF co-exist in the same dimer (Fig. 6C).
In a third approach, a ﬂexibility characterization was performed
using EOM2.0 [42], to assess potentialﬂexibility of theNTDwith respect
to the CTD. The quantiﬁcation of the ﬂexibility (Rﬂex) is given by
Rﬂex = ~77%, 73% and 73% for selected ensemble distribution of the
Fig. 5. Solution X-ray scattering studies of EcAhpF. (A) Small angle X-ray scattering pattern (○) of EcAhpF in apo- (green), NADH- (red) and NAD+-bound (blue) forms are displayed in log-
arithmic units for clarity. (Insert) Guinier plots show linearity for all three forms, indicating no aggregation. (B) Pair-distance distribution function P(r) of the three forms of EcAhpF. (C)
Normalized Kratky plot of EcAhpF apo- (green), NADH- (red) and NAD+-bound (blue) forms compared to the compact globular lysozyme (cyan) with the expected peak (dashed line)
representing the theoretical peak assuming an ideal Guinier region of a globular particle. The CTD212–521 (brown) domain, which is a rigid molecule, is also shown for comparison. The
bell shape vanishes for three different forms of intact AhpF exhibiting the ﬂexible nature. (D) The Porod–Debey plot for three different forms of EcAhpF does not converge to a plateau
conﬁrming further the ﬂexibility of the three forms.
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nature of EcAhpF when compared to the values derived from the origi-
nal random pool (pool Rﬂex = ~87%). The quality of the ensemble solu-
tionwas further conﬁrmed by the control value Rσ=0.68, 0.88 and 0.57
for the apo-, NADH- and NAD+-forms, respectively (expected to be
lower than 1.0 when ensemble Rﬂex b pool Rﬂex). The distribution of the
Rg-value of the particle in the initial pool and in the selected ensemble
is shown in Fig. 7A. The Rg-distributions of the randompools for all sam-
ples are rather broad, about 30 to 55 Å, whereas the selected ensembles
of the apo-, NADH- and NAD+-forms display relatively narrow distribu-
tions with Rg-average values below the Rg-average values from the ran-
dom pool (Fig. 7A). The Rg-distributions for the selected ensembles
display a clear maximum at Rg values 39–40 Å for all three forms,followed by a less pronounced shoulder at Rg values of 42 Å and 36 Å
for the apo-form but with a prominent shoulder at 36 Å for the
NADH- and NAD+-bound forms. The selected ensemble with the best
ﬁt (χ2 = 0.38, 0.44, 0.55 for the apo-, NADH- and NAD+-forms of
EcAhpF, respectively; Fig. 7B) contains representatives of four con-
formers (Fig. 7C–E) and their Rg-values mirror the peak positions of
the Rg-histogram. In the selected ensemble, the EcAhpF adopts highly
extended (mean Rg-value of 44 Å) and bent (mean Rg-value of 37 Å)
conformations for the apo-formwith 40% and 60% of the population, re-
spectively, while in the case of the NADH- and NAD+-bound forms, the
extended conformation (Rg-values of 40–41 Å) is populated to about
60% and 70% and the compact conformation (Rg-value of 36 Å) is popu-
lated to about 40% and 30%, respectively.
Fig. 6. Structural modeling of EcAhpF based on SAXS. (A) Oligomer ﬁts between experimental scattering data (○) of the three forms of EcAhpF (apo (green), NADH (red) and NAD+ (blue))
and theoretical scattering pattern (—) calculated using open and closed dimers of EcAhpF structures. (B) Fit of the scattering proﬁle of the CORALmodel (—) with theχ2 value of 0.55, 0.44
and0.76 to the experimental scattering pattern (○) of EcAhpF in the apo-, NADH- andNAD+-forms, respectively. (C) The superimposedCORAL-model generated for three forms of EcAhpF.
The ﬁxed C-terminal domain (cartoon) colored bright and dull yellow for dimer and the linker region (sphere) is coloredmagenta. The compact and the extended NTDs (surface) are col-
ored green, red and blue for the apo-, NADH- and NAD+-forms, respectively. The extended and compact states coexist in all the three forms.
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4.1. Sequential steps during electron transfer in EcAhpF
In order to function as an AhpC reductase, E. coliAhpF has to undergo
at least ﬁve sequential steps: (I) NADH-binding for (II) electron transfer
via FAD to the (III) NADH-domain disulﬁde center and further to the
(IV) redox active motif 129CXXC132 in the NTD, which (V) allows the re-
duction of the two conserved redox-active cysteines in AhpC for reduc-
tion of H2O2. The structural details available until now for AhpF
represent the ﬂavin oxidized state (FO-state) of the NADH-domain, al-
though it is proposed that the electron transfer in AhpF undergoes
two distinct conformations called the ﬂavin oxidized (FO) and ﬂavin re-
duced (FR) state [11,13,14]. The ﬁrst crystal structure of the NADH-
bound EcAhpF presented here provides valuable insights into thealternative conformation of the NADH-domain during the electron
transfer process. The NADH-bound EcAhpF structure shows that the di-
sulﬁde center (345CXXC348) is buried and in close proximity to the
isoalloxazine-ring of the FAD moiety at a distance of 3.05 Å. In the
bound NADH-form, the nicotinamide-ring is placed on the surface of
the enzyme and oriented towards the FAD-binding domain, which is
about 17 Å away from the isoalloxazine-ring of ﬂavin (Fig. 1A). There-
fore, it is unlikely that the hydride transfer would happen between the
nicotinamide- and isoalloxazine-rings at this distance implying, that
the present structure is in an FR-initiation state whereby NADH is
bound on the surface in order to initiate the FR-state, i.e., to reduce the
FAD, the NADH-domain of EcAhpF requires a rotation of about 65°.
When such a magnitude of rotation (~65°) is applied to the NADH-
domain, the nicotinamide-ring of NADH stacks well against the re-face
of the isoalloxazine-ring of the FAD molecule, to favor the hydride
Fig. 7. Flexibility analysis of EcAhpF using EOM. (A) Comparison between the Rg distributions (pool,— (shaded); ensemble,—) shows a non-random ﬂexibility as conﬁrmed by Rﬂex of 78%,
73% and 73% comparedwith an 87% threshold value for randomness and Rσ value of 0.46 for the apo-, NADH- and NAD+-forms, respectively. (B) Experimental scattering pattern (○) and
calculated ensemble scattering proﬁles (—; black) with discrepancy χ2 = 0.38, 0.44 and 0.55 for the apo-, NADH- and NAD+-forms, respectively. The selected ensemble models with the
ﬂexible NTDs (surface) in different colors for (C) apo (green), (D) NADH- (red) and (E) NAD+-bound forms (blue) are presented. (F) Comparison of Rg-values with their Dmax for the two
predominant conformers for the apo (green) and substrate (blue) bound forms. For clarity, onlymonomers are shown. The ratio of the two conformers is represented by the size of thedots
in each group. The apo-form adopts highly extended (40%) and bent (60%) conformations, while the substrate-bound forms prefer extended (70%) and compact (30%) conformations.
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Fig. 8. Proposed catalyticmechanism of EcAhpF. The overall catalyticmechanismof EcAhpF is shown by a four-step process (1–4). TheNTD undergoes rearrangements during catalysis. Some
of the representative extended (NTDex) and compact (NTDco) conformations of theNTD in solution are shownby ribbon representation. (1) In the apo-formof EcAhpF, theNADH-domain
adopts the FO-conformation and FAD is in the reduced state as FADH2. (2) The substrate NADH binds at the desired position in the NADH-binding domain and the FADH2 reduces the
Cys345/Cys348. (3) The NADH-domain twists about 65°, leading to an FR-conformation, such that the nicotinamide ring of NADH stacks well against the isoalloxazine-ring to reduce
FAD. The Cys345/348 pair is now exposed for reduction by the NTD redox active center. The ﬂexible NTD preferably adopts a compact conformation (NTDco) to make contact with the
NADH-domain for electron transfer to occur. (4) The NADH-domain rotates back to the FO-state, and leaves the NAD+-molecule. The extended conformations of the NTD preferably
bind the substrate protein to reduce the disulﬁde bond of AhpC.
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posed so as to reduce the NTD disulﬁde center (Fig. 8). In comparison,
the variation in the conformation of the nicotinamide moiety in the
NAD+-molecule renders it unsuitable for a hydride transfer, as it does
not stack against the isoalloxazine-ring of FAD, when a similar rotation
of theNADH-domain ismade. Therefore,we propose that the conforma-
tion adopted byNAD+ in theNAD+-bound EcAhpF structuremost likely
represents an intermediate product-release conformation.4.2. Intrinsic dynamics of EcAhpF and the substrate induced compactness
EcAhpF is a three domain protein where the NTD is tethered to the
CTD (the latter of which contains FAD and NADH domains) by a highly
ﬂexible linker region. Such multi-domain protein organizations are
abundant in nature (65% in prokaryote and 70% in eukaryote) and are
often associated with ﬂexibility, which in turn implicates the presence
of several different protein conformations in solution [42,49]. This
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networks and for their regulatorymechanisms [50]. Reproducing the in-
herent ﬂexibility of biomolecules is a challenge and recently ﬂexibility
analysis in solution by small-angle X-ray scattering (SAXS) has become
a central tool in characterizing multi-state systems [11,42] where crys-
tallography, NMR and electron microscopy methods have limited scope
[50]. Flexibility analysis using SAXS ensemble methods has been suc-
cessfully applied to several biological systems such as, polynucleotide
kinase [51], Lys-63 linked tetraubiquitin [52], Hck tyrosine kinase [53],
ubiquitin–PCNA complex [54], endosome-associated ESCRT-III CHMP3
domain [55], non-structured proteins of Dengue [56], and the vacuolar
ATPase [31].
The small angle X-ray scattering proﬁles of the NTD and CTD [11] in-
dicate that each domain is rigid as inferred from the Kratky plot and the
dimensions of the domains which compares well with the crystal struc-
tures (Fig. 5C). Scattering proﬁles of the apo-, NADH- and NAD+-bound
forms of EcAhpF indicate that the experimental radius of gyration (Rg)
(37–39 Å) values are in between the calculated Rg-values of the crystal
structures of the extended (PDB ID: 4O5Q; Rg=47 Å) and the compact
(PDB ID: 1HYU; Rg=36 Å) states, suggesting that intermediate confor-
mations or a mixture of different conformations might be present in
solution (Table 2). The scattering proﬁle also revealed the ﬂexible
nature of the proteins as conﬁrmed by the normalized Kratky and
Porod–Debey plots as well as from the mixed population deduced by
oligomer and rigid body modeling, which suggest the presence of a
mixture of different conformations. Furthermore, the proﬁles alsoTable 2
Data collection and scattering derived parameters for EcAhpF in three forms.
Data collection parameters
Instrument (source & detector) Bruker NanoStar equipped with
MetalJet eXcillum
VANTEC 2000
Beam geometry 100 μm slit
Wavelength (Å) 1.34
s range (Å−1) 0.016–0.4
Exposure time (min) 30 (6 frames × 5 min)
Protein sample apo NADH NAD+
Concentration range (mg ml−1) 1–4 1–4 1–4
Temperature (K) 288 288 288
Structural parameters
I(0) (cm−1) [from P(r)] 79.82 ±
0.8
65.02 ±
0.7
66.56 ±
0.5
vRg (Å) [from P(r)] 40.2 ±
0.4
38.85 ±
0.3
39.14 ±
0.3
I(0) (cm−1) (from Guinier) 79.59 ±
1.3
63.63 ±
1.3
65.32 ± 1
Rg (Å) (from Guinier) 39.3 ±
0.8
37.23 ± 1 37.37 ±
0.8
Dmax (Å) 129.5 ± 3 120.4 ± 1 120.3 ± 2
Porod volume estimate (Å3) ~146,613 ~143,671 ~139,179
Dry volume from sequence (Å3) ~67,972 ~67,972 ~67,972
Molecular mass determination
Calculated monomericMM (kDa) [from
sequence]
~56 ~56 ~56
Molecular massMM (kDa)
[from Porod invariant]
92 ± 10 90 ± 10 87 ± 10
Molecular massMM (kDa)
[from SAXS MoW]
105 ± 10 99 ± 10 94 ± 10
Molecular massMM (kDa)
[from volume of correlation, Vc [57]]
100 ± 10 98 ± 10 93 ± 10
Software employed
Primary data reduction BRUKER SAS
Data processing PRIMUS
Ab initio analysis DAMMIN
Validation and averaging DAMAVER
Computation of model intensities CRYSOL
Rigid body modeling CORAL
Flexibility EOM 2.0
3D graphics representations PyMOLindicated that the addition of substrates did not signiﬁcantly affect the
ﬂexibility of the apo-form (Fig. 5C–D).
In order to ascertain the predominant conformations of the apo-,
NADH- and NAD+-bound enzymes in solution, the ensemble optimiza-
tion method (EOM, [24]) was used wherein the ﬂexibility of the NTD
(introduced by the 17 residue linker) with respect to the CTD is consid-
ered. The calculations revealed that the apo-form has a pool of highly
extended and bent conformations (mean Rg-value of 37 and 44 Å;
hence the NTD and NADH-domains do not interact), whereas the
NADH- and NAD+-bound forms have two conformational pools, the
majority 60–70% of the population is extended (Rg ranging from 40 to
41 Å) and the remaining 30–40% of the population is compact
(Rg around 36 Å; hence the NTD and NADH-domains are close enough
to interact) (Fig. 7F). These differences in the population of extended
vs. compact states within the apo- and substrate-bound forms are pro-
posed to cause the variations in the Rg-values, maximum particle di-
mension (Dmax), and in the distance distribution function (P(r)) (Fig. 4
and Table 2). Furthermore, the selected ensembles of a highly extended
conformational pool with Rg-values around 44 Å, including about 40% of
particles in the apo-form, indicate that their shape resembles that of the
extended crystal structure (albeit with a different domain orientation)
(Fig. 7F). Moreover, the addition of NADH or NAD+ hinders the forma-
tion of a highly extended form and induces a fraction of the protein to
adopt a compact state. This compact state, accounting for 30–40% of
the particles in NADH-bound form, mimics the closed conformation,
which enables the electron transfer between the disulﬁde centers of
the NTD and NADH domains (Fig. 7F). In addition, the presence of two
predominant conformations (60% and 70% of particleswith bent and ex-
tended states in the apo- and NADH-bound forms, respectively) within
a broad range of Rg-values (37–44 Å) hint at the existence of multiple
conformations in solution (Fig. 7 F). These studies reveal the ﬂexible na-
ture of EcAhpF with the NTD existing in several different conformations
in solution, which is vital for its catalytic function and also for the pref-
erential binding of EcAhpC.
5. Conclusions
The NADH- and NAD+-bound crystal structures and the SAXS-
solution analysis of EcAhpF reveal the conformational alterations
adopted by AhpF during the electron transfer mechanism. The NADH-
bound structure represents a so-called FR-initiation state in which a re-
arrangement of the NTD (8°) relative to the CTD and conformational al-
terations in NADH-binding is proposed to initiate the necessary rotation
to bring the NADH close enough to FAD for the reduction to occur. The
solution studies demonstrate that the linker enables the transient
movements of the NTD relative to the CTD so that the apo-form of
EcAhpF undergoes a rearrangement after NADH-binding (8°) via bent-
like conformations to the compact form of the enzyme in which
electrons from the redox-active center (C345/C348) of the CTD can be
transferred to the disulﬁde center (C129/C132) of the NTD, thereby
completing the electron transfer from the substrate NADH to the
C-terminal disulﬁde center through FAD. The conformational ﬂexibility
of EcAhpF in solution is essential for a subsequent rearrangement to an
extended-form of EcAhpF which enables binding and reduction of its
enzymatic partner EcAhpC. The NAD+-bound EcAhpF structure,
proposed to represent an intermediate product-release conformation,
provides insight into how arrangements occur inside AhpF to ﬁnish
one enzymatic cycle and to prepare AhpF for a new round of NADH-
binding, thereby providing electrons for a new catalytic cycle.
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